✦ LIBER ✦

Synovial tissue responses following treatment of rheumatoid arthritis with the humanized monoclonal antibody CAMPATH-1H

✍ Scribed by Enrique R. Soriano; Jonathan Dixey; Nicolas D. Hall; Joan Davies; Peter J. Maddison

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 212 KB
Volume: 39
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780390132

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of active refractory rheumatoi

Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody campath-1h administered by daily subcutaneous injection

✍ Eric L. Matteson; David E. Yocum; E. William St. Clair; Antonio A. Achkar; Micha 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Objective. To investigate the dose tolerance and potential clinical activity of a humanized antilymphocyte monoclonal antibody, CAMPATH-1H (ClH), in patients with active, refractory rheumatoid arthritis (RA). Methods. Thirty adult patients with active, refractory RA were treated in an open-label, 3

Treatment of rheumatoid synovitis with a

Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: Use of rheumatoid arthritis tissue implants in the SCID mouse model

✍ H. Matsuno; T. Sawai; T. Nezuka; M. Uzuki; H. Tsuji; N. Nishimoto; K. Yoshizaki 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 934 KB

Ocrelizumab, a humanized anti-CD20 monoc

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study

✍ Mark C. Genovese; Jeffrey L. Kaine; Mitchell B. Lowenstein; José Del Giudice; An 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

LY2439821, a humanized anti–interleukin-

LY2439821, a humanized anti–interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

✍ M. C. Genovese; F. Van den Bosch; S. A. Roberson; S. Bojin; I. M. Biagini; Peter 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Treatment with monoclonal anti–tumor nec

Treatment with monoclonal anti–tumor necrosis factor α antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis

✍ Madelon M. Maurice; Wiebo L. Van Der Graaff; Angela Leow; Ferdinand C. Breedveld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

Ofatumumab, a human anti-CD20 monoclonal

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study

✍ Mikkel Østergaard; Bo Baslund; William Rigby; Bernadette Rojkovich; Christian Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views